Veristat Case Studies
-
CGT Team Guides Troubled Rare Disease Programs To Success
11/2/2020
Uncover how a clinical-stage biotechnology start-up received assistance in genetic material handling, relationships with key global regulatory agencies, and expertise in accelerated pathways to approval.
-
Stem Cell Therapy For Stroke Patients
11/2/2020
A client engaged the Veristat team in a Phase II study of intracerebral stem cell injection in patients following an ischemic stroke. The goal was to look at limb recovery time and level in patients with stroke. The effort began with identifying the best time for a product to be delivered and then expanded into full-service involvement, including project management, clinical monitoring, medical writing, and regulatory affairs. Learn how we overcame unique challenges in this multi-center trial that led to the client publishing positive Phase IIa data.
-
Full Service Support For A Gene Therapy Trial
11/2/2020
A clinical-stage biotechnology start-up asked Veristat to run complex US and EU trials of their unique gene therapy. Veristat brought invaluable global capabilities and expertise to a small client team tackling their first clinical-stage program without the large infrastructure or resources to conduct studies in this space themselves. Our end-to-end support started at Phase I and will continue into post-marketing and regulatory follow-up.